Laporan Laba Rugi (TTM)
Laporan Laba Rugi Rhythm Biosciences Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Change (%) | 84.72 | -4.14 | -4.32 | 59.49 | 37.30 | 0.00 | 0.00 | 6.05 | 5.70 | 6.89 | 6.45 | -16.65 | -19.97 | -9.08 | -9.98 | 43.67 | 30.40 | 0.40 | 0.40 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 0 | 1 | 0 | 1 | 1 | 1 | -0 | -1 | -0 | 1 | 2 | 3 | 3 | 1 | -1 | -0 | 0 | |||
Change (%) | 100.00 | -50.00 | 100.00 | -50.00 | 100.00 | -50.00 | 100.00 | 24.78 | 19.86 | -63.94 | -177.34 | -63.23 | -171.97 | |||||||
% of Revenue | 38.58 | 41.78 | 21.79 | 39.18 | 57.07 | 28.53 | -9.78 | -18.50 | -8.65 | 39.48 | 98.68 | 135.42 | 180.31 | 45.25 | -26.84 | -9.83 | 7.05 | |||
Gross Operating Profit | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 0 | -1 | -1 | 1 | 4 | 3 | 3 |
Change (%) | 75.11 | 28.77 | 22.34 | -2.99 | -3.09 | 66.46 | 39.93 | 16.42 | 14.10 | -1.99 | -2.03 | -49.56 | -98.25 | -2,535.66 | 104.11 | -197.94 | 202.10 | -13.06 | -15.02 | |
% of Revenue | 61.42 | 58.22 | 78.21 | 100.00 | 60.82 | 42.93 | 71.47 | 100.00 | 109.78 | 118.50 | 108.65 | 100.00 | 60.52 | 1.32 | -35.42 | -80.31 | 54.75 | 126.84 | 109.83 | 92.95 |
SG&A | 2 | 3 | 3 | 3 | 4 | 5 | 6 | 6 | 6 | 6 | 7 | 8 | 6 | 5 | 4 | 3 | 3 | 4 | 4 | 5 |
Change (%) | 13.94 | 5.03 | 4.79 | 35.68 | 26.30 | 7.60 | 7.06 | 2.65 | 2.58 | 11.07 | 9.97 | -17.78 | -21.63 | -19.71 | -24.55 | 9.99 | 9.08 | 20.96 | 17.33 | |
% of Revenue | 369.55 | 227.95 | 249.76 | 273.53 | 232.69 | 214.04 | 230.31 | 246.57 | 238.67 | 231.62 | 240.69 | 248.66 | 245.27 | 240.18 | 212.08 | 177.75 | 136.09 | 113.85 | 137.16 | 160.28 |
R&D | 2 | 2 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 1 |
Change (%) | 0.00 | 67.42 | 40.27 | 0.00 | 0.00 | 6.64 | 6.22 | 0.00 | 0.00 | -14.65 | -17.16 | 0.00 | 0.00 | -17.85 | -21.73 | 0.00 | 0.00 | -20.50 | -25.79 | |
% of Revenue | 296.43 | 160.48 | 280.28 | 410.89 | 257.63 | 187.64 | 200.09 | 212.54 | 200.42 | 189.61 | 151.40 | 117.83 | 141.36 | 176.64 | 159.60 | 138.78 | 96.60 | 74.08 | 58.66 | 43.36 |
OpEx | 5 | 5 | 7 | 8 | 9 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 11 | 11 | 10 | 9 | 7 | 5 | 6 | 7 |
Change (%) | 12.51 | 22.26 | 18.21 | 22.77 | 18.55 | -0.04 | -0.04 | -0.65 | -0.65 | 1.96 | 1.92 | -3.00 | -3.09 | -10.37 | -11.56 | -19.24 | -23.82 | 15.44 | 13.37 | |
% of Revenue | 726.98 | 442.79 | 564.72 | 697.65 | 537.01 | 463.66 | 463.47 | 463.29 | 434.05 | 407.98 | 389.15 | 372.60 | 433.63 | 525.13 | 517.69 | 508.60 | 285.90 | 167.03 | 192.04 | 216.85 |
Operating Income | -4 | -4 | -5 | -7 | -8 | -9 | -9 | -9 | -9 | -8 | -8 | -8 | -9 | -9 | -8 | -7 | -5 | -2 | -3 | -4 |
Change (%) | 0.99 | 29.96 | 23.05 | 16.62 | 14.25 | -0.05 | -0.05 | -2.49 | -2.55 | 0.35 | 0.35 | 2.01 | 1.97 | -10.67 | -11.94 | -34.63 | -52.98 | 37.87 | 27.47 | |
% of Revenue | -626.98 | -342.79 | -464.72 | -597.65 | -437.01 | -363.66 | -363.47 | -363.29 | -334.05 | -307.98 | -289.15 | -272.60 | -333.63 | -425.13 | -417.69 | -408.60 | -185.90 | -67.03 | -92.04 | -116.85 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||
Change (%) | -0.00 | -42.42 | -73.69 | -0.00 | -0.00 | -50.04 | 99.97 | 12.55 | 11.14 | -30.85 | -44.59 | 897.87 | 89.98 | 5.99 | 5.65 | |||||
% of Revenue | -1.19 | -0.65 | -0.39 | -0.11 | -0.07 | -0.05 | -0.02 | -0.11 | -0.21 | -0.29 | -0.40 | -0.30 | -0.19 | -1.29 | -1.88 | -1.99 | -2.09 | |||
Net Income | -4 | -4 | -5 | -7 | -8 | -9 | -9 | -9 | -9 | -8 | -8 | -8 | -8 | -9 | -8 | -7 | -5 | -2 | -3 | -4 |
Change (%) | 1.19 | 30.25 | 23.22 | 16.69 | 14.30 | -0.14 | -0.14 | -3.08 | -3.18 | -0.21 | -0.21 | 2.51 | 2.45 | -10.27 | -11.45 | -34.13 | -51.82 | 37.99 | 27.53 | |
% of Revenue | -622.29 | -340.89 | -463.18 | -596.49 | -436.41 | -363.31 | -362.78 | -362.26 | -331.09 | -303.28 | -283.14 | -265.44 | -326.44 | -417.89 | -412.40 | -405.69 | -186.00 | -68.73 | -94.45 | -119.97 |
Source: Capital IQ